Data Management

In this video interview with ACT editor Andy Studna, Rich Gliklich, MD, founder of OM1 discusses how real-world data can be useful throughout the different stages of a trial.

Session provides insight as to how to boost interoperability and expand the middleware on a global scale.

Compliance with diverse clinical trial payment and data standards requires specialized skills.

Webinar Date/Time: Wed, Sep 25, 2024 11:00 AM EDT

Maximizing the impact of data is only possible when strong fundamental data management capabilities are in place.

In part 2 of this video interview, Jim Murphy, CEO of Greenphire discusses how access to data can impact elements such as budgeting and enrollment.

Webinar Date/Time: Thursday, September 19th, 2024 at 11am EDT|8am PDT|4pm BST|5pm CEST

A use case by Memorial Sloan Kettering Cancer Center explores the potential of EHR-to-EDC.

Webinar Date/Time: Wednesday, September 11th, 2024 at 11am EDT|8am PDT|4pm BST|5pm CEST

Webinar Date/Time: Thursday, September 12th, 2024 at 11am EDT|8am PDT|4pm BST|5pm CEST

Five industry leaders share their perspectives on the evolution of DCTs.

Webinar Date/Time: Tuesday, September 10th, 2024 at 11am EDT|8am PDT|4pm BST|5pm CEST

Webinar Date/Time: Tuesday, August 27, 2024 at 11:00 AM EDT | 8:00 AM PDT | 4:00 PM BST | 5:00 PM CEST

Webinar Date/Time: Tuesday, August 13th, 2024 at 11am EDT|8am PDT|4pm BST|5pm CEST

Webinar Date/Time: Thursday, June 27th, 2024 at 11am EDT|8am PDT|4pm BST|5pm CEST

Webinar Date/Time: Tuesday, June 25th, 2024 at 11am EDT|8am PDT|4pm BST|5pm CEST

Six trends to help guide trial master file strategy.

A more user-centered design can allow increased flexibility in the development of eCOA platforms, driving better engagement and participation.

Companies must be able to defend the fidelity and confidentiality of all records and data generated throughout a product’s entire lifecycle, starting with the earliest points in research.

Promising scientific advances are pacing oncology drug development.

Webinar Date/Time: Tuesday, May 21st, 2024 at 2pm PDT | 5pm EDT | 11pm CEST

Despite the significance offered by AI to pharmaceutical companies, there are several challenges that must be overcome for successful integration of tech-based tools.

A look at the lessons learned from one platform approach to study enrollment tracking—and the wider quest for accountability in achieving diversity and inclusion goals.

In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.

In part 2 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA discusses best practices for understanding specific therapeutic areas and deploying an effective eCOA strategy.